Neurotransmitter‐Mimicking Nanovesicles Facilitate Postoperative Glioblastoma Stem Cell‐Specific Treatment for Preventing Tumor Recurrence
Advanced Science · 2025
DOI: 10.1002/advs.202409713 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Fuming Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, 1 Friendship Road, Chongqing, 400016, P. R. China. Hauptthemen laut MEDLINE: Glioblastoma, Neoplastic Stem Cells, Neoplasm Recurrence, Local, Neurotransmitter Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Survival quality of glioblastoma (GBM) patients remains undesirable despite the aggressive multimodal treatment methods implemented, which are strongly associated with tumor recurrence after surgical resection. Self‐renewal and strong tumourigenic capacity of glioblastoma stem cells (GSCs) at the narrow margin of the incision are essential factors driving tumor secondary strikes. Currently, the challenges in treating postoperative residual GSCs are mainly due to the lack of materials for incision and GSCs targeting. In this study, a neurotransmitter‐mimicking nanovesicle (PMVS‐P) based on platelet membrane‐derived vesicle (PMV) with anti‐GSC drug salinomycin (SAL)‐loading and polydopamine (PDA)‐surface is synthesized. PMVS‐P exhibits surgical incision targeting ability and specifically identified GSCs with highly expressed D2 dopamine receptor (D2DR), a central nervous system neurotransmitter receptor, thus suppressing GBM recurrence. This neurotransmitter‐mimicking nanovesicle primed GSC‐specific tumoricidal treatment with broadened applications for preventing tumor recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, 1 Friendship Road, Chongqing, 400016, P. R. China.
- CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscie…
- University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.
- Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, 1 Friendship Road, Chongqing, 400016, P. R. China.
ORCID-Profile: Ling Zhu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Liang, F., You, Q., Yu, B., Wang, C., Yang, Y., Zhu, L., & He, Z. (2025). Neurotransmitter‐Mimicking Nanovesicles Facilitate Postoperative Glioblastoma Stem Cell‐Specific Treatment for Preventing Tumor Recurrence. Advanced Science. https://doi.org/10.1002/advs.202409713
Vancouver
Liang F, You Q, Yu B, Wang C, Yang Y, Zhu L, et al. Neurotransmitter‐Mimicking Nanovesicles Facilitate Postoperative Glioblastoma Stem Cell‐Specific Treatment for Preventing Tumor Recurrence. Advanced Science. 2025. doi:10.1002/advs.202409713
BibTeX
@article{Liang2025,
author = {Liang, Fuming and You, Qing and Yu, Bin and Wang, Chen and Yang, Yanlian and Zhu, Ling and He, Zhaohui},
title = {Neurotransmitter‐Mimicking Nanovesicles Facilitate Postoperative Glioblastoma Stem Cell‐Specific Treatment for Preventing Tumor Recurrence},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202409713}
}
EUVIMED